BE766072A - Complexes de sulfanilyl-phenyluree utiles pour la lutte contre la maladie de marek - Google Patents

Complexes de sulfanilyl-phenyluree utiles pour la lutte contre la maladie de marek

Info

Publication number
BE766072A
BE766072A BE766072A BE766072A BE766072A BE 766072 A BE766072 A BE 766072A BE 766072 A BE766072 A BE 766072A BE 766072 A BE766072 A BE 766072A BE 766072 A BE766072 A BE 766072A
Authority
BE
Belgium
Prior art keywords
phenyluree
sulfanilyl
marek
complexes
disease
Prior art date
Application number
BE766072A
Other languages
English (en)
French (fr)
Inventor
W V Ruyle
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BE766072A publication Critical patent/BE766072A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE766072A 1970-04-22 1971-04-21 Complexes de sulfanilyl-phenyluree utiles pour la lutte contre la maladie de marek BE766072A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3102570A 1970-04-22 1970-04-22

Publications (1)

Publication Number Publication Date
BE766072A true BE766072A (fr) 1971-10-21

Family

ID=21857254

Family Applications (1)

Application Number Title Priority Date Filing Date
BE766072A BE766072A (fr) 1970-04-22 1971-04-21 Complexes de sulfanilyl-phenyluree utiles pour la lutte contre la maladie de marek

Country Status (9)

Country Link
US (1) US3717623A (de)
BE (1) BE766072A (de)
CA (1) CA951726A (de)
CH (1) CH554874A (de)
DE (1) DE2119451A1 (de)
FR (1) FR2092072B1 (de)
GB (1) GB1311618A (de)
NL (1) NL7104785A (de)
ZA (1) ZA712566B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960955A (en) * 1974-11-15 1976-06-01 Texaco Inc. Purification process
US3998853A (en) * 1975-12-04 1976-12-21 Phillips Petroleum Company 13-Oxatetracyclo[8.2.12,9.0.03,8 ]tridec-5-ene-1,5,6,10-tetracarbonitrile
US4338334A (en) * 1977-12-29 1982-07-06 Merck & Co., Inc. 1-[4-(4-Sulfanilyl)phenyl] urea and derivatives in compositions and methods of treating rheumatoid arthritis and immune complex diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2328548A (en) * 1939-05-27 1943-09-07 Schering Corp Therapeutically valuable derivative of sulfones
GB987252A (en) * 1960-08-29 1965-03-24 Monsanto Canada Ltd Bacteriostatic adducts of pyridine and pyrimidine derivatives

Also Published As

Publication number Publication date
US3717623A (en) 1973-02-20
DE2119451A1 (de) 1971-11-11
CH554874A (de) 1974-10-15
CA951726A (en) 1974-07-23
FR2092072A1 (de) 1972-01-21
ZA712566B (en) 1972-12-27
FR2092072B1 (de) 1974-05-24
GB1311618A (en) 1973-03-28
NL7104785A (de) 1971-10-26

Similar Documents

Publication Publication Date Title
BE813795A (fr) Systeme pour l&#39;execution d&#39;operations bancaires
BE792326A (fr) Procede pour la preparation d&#39;halogenohydrines
BE790089A (fr) Derives de l&#39;imidazole
BE796501A (fr) Jeu d&#39;elements pour meubles
BE767299A (fr) Procede pour la preparation d&#39;esters d&#39;aspartyle-amino-acides
BE780576A (fr) Therapie d&#39;association pour la maladie de parkinson
LU64117A1 (fr) Stimulateur d&#39;effort pour commandes de vol
PH13020A (en) 3-(1h-tetrazol 5 yl)-chromone derivatives
CA972819A (en) Procede pour focaliser le faisceau d&#39;une soudeuse electronique
RO63724A (fr) Procede pour la preparation des derives d&#39;oxadiazolone
BE766072A (fr) Complexes de sulfanilyl-phenyluree utiles pour la lutte contre la maladie de marek
RO63792A (fr) Procede pour la preparation d&#39;ergolines-0-6-methyle-2-8-substituees
RO62900A (ro) Procedeu pentru prepararea unor n-benzhidril-n&#39;-p-hidroxibenzilpiperazine
BE764707A (fr) Agents pour la regulation de la croissance des
BE764203A (fr) Procede pour la preparation d&#39;indenophtalazines
BE797631A (fr) Mecanisme d&#39;actionnement pour tiroirs
BE770523A (fr) Procede pour l&#39;obtention d&#39;hellebrine
IT954872B (it) Procedimento per la preparazione di 6 idrossi cromani
BE773374A (fr) Procede pour l&#39;exploitation de la scorie
BE771084A (fr) Faisselle pour l&#39;obtention de fromages
BE772975A (fr) Catalyseur pour l&#39;oxydation de composes organiques
BE763243A (fr) Procede pour la production d&#39;une enzyme dextranase
BE761685A (fr) Procede pour la preparation d&#39;isoxazolylethyl-tetrahydropyranols
BE774307A (fr) Procede pour la preparation d&#39;alcenylnorbornenes
BE802595A (fr) Piece pour la realisation d&#39;assemblages